Agilent, Groton Co-Market 1200 HPLC to Improve Rx Quality
Agilent Technologies and Groton Biosystems will jointly market Agilent’s 1200 Series high performance liquid chromatography system with Groton’s Automated Reactor Sampling ARS Series Online Process Autosampling products under an agreement announced this week.
Financial details of the agreement were not disclosed.
The two companies formed the alliance for the Process Analytical Technology initiative, an effort led by the US Food and Drug Administration for designing, analyzing, and controlling manufacturing by the pharmaceutical industry with the goal of improving product quality.
The Agilent-Groton deal is effective only in the US and Canada for now but is expected to expand to Europe and Asia in the “near future,” the companies said in a joint statement.
Control Software Integrating Waters’ Acquity with ABI/MDS Sciex MS Released
Waters announced late last week it has released control software to integrate its Acquity UPLC system with ABI/MDS Sciex’s mass spectrometers.
In August, the two companies announced they had reached an agreement to develop software allowing researchers to use the Acquity instrument with the ABI/MDS Sciex mass spec from a single platform.
AMEX Tells Bio-Rad it Needs One More Director
Bio-Rad said late last week it has received a letter from the American Stock Exchange saying the death of former board member Philip Padou has left the company in non-compliance with AMEX rules. Padou died over the New Year’s weekend leaving Bio-Rad with two independent directors, one less than the required three independent directors under AMEX rules.
The exchange gave Bio-Rad until April 9 to regain compliance. Bio-Rad said it is currently seeking a replacement for Padou.